One of the most pursued approaches in DMD is to promote oxidative metabolism in skeletal muscle and in this regard, one beneficial target is PPARδ which increases fatty acid oxidation, sparing glucose use and greatly improving energy production [130]. This evidence concerns the gene PPARD and Duchenne muscular dystrophy.